å»çæ å ±ã·ã¹ãã ã®å¥ç´ã«ãããå½äºè éã®å½¹å²åæ çã«é¢ãã確èªè¡¨ï¼PDFå½¢å¼ï¼1,028KBï¼ å»çæ å ±ã·ã¹ãã ã®å¥ç´ã«ãããå½äºè éã®å½¹å²åæ çã«é¢ãã確èªè¡¨ï¼Excelå½¢å¼ï¼25KBï¼ ï¼å¥æ·»1ï¼å»çæ å ±ã·ã¹ãã ã®å¥ç´ã«ãããå½äºè éã®å½¹å²åæ çã«é¢ãã確èªè¡¨ æ¨å¥¨ããã対å¿ä¾ï¼PDFå½¢å¼ï¼967KBï¼ ï¼å¥æ·»2ï¼å»çæ å ±ã·ã¹ãã ã®å¥ç´ã«ãããå½äºè éã®å½¹å²åæ çã«é¢ãã確èªè¡¨ ç¨èªã®è§£èª¬ï¼PDFå½¢å¼ï¼784KBï¼ ï¼å¥æ·»3ï¼æ°è¦ã·ã¹ãã ã®å°å ¥ã«éãã¦ã®å»çæ å ±ã·ã¹ãã ã®å¥ç´ã«ãããå½äºè éã®å½¹å²åæ çã«é¢ãã確èªè¡¨ã®å©ç¨ã¤ã¡ã¼ã¸ï¼PDFå½¢å¼ï¼1,232KBï¼ ãååãå ååæ å ±æ¿çå± ååãµã¼ãã¹ã°ã«ã¼ã ãã«ã¹ã±ã¢ç£æ¥èª² é»è©±ï¼03-3501-1511ï¼å ç·ï¼4041ï½4043ï¼
å»çæ å ±ã®å®å ¨ç®¡çã®ãããå»çæ å ±ãåãæ±ãæ å ±ã·ã¹ãã ããµã¼ãã¹ã®æä¾äºæ¥è ãéµå®ãã¹ãå 容ã¨ãã¦ãç·åçåã³çµæ¸ç£æ¥çã§ã¯ã令å2å¹´8æã«ãå»çæ å ±ãåãæ±ãæ å ±ã·ã¹ãã ã»ãµã¼ãã¹ã®æä¾äºæ¥è ã«ãããå®å ¨ç®¡çã¬ã¤ãã©ã¤ã³ããå ¬è¡¨ããããã«ä»¤å5å¹´7æãåã¬ã¤ãã©ã¤ã³ç¬¬1.1çãã¸ã¨æ¹å®ãã¾ããã åã¬ã¤ãã©ã¤ã³ã«ã¤ãã¦ãè¿å¹´ã®ãµã¤ãã¼æ»æã®å¤æ§åã»å·§å¦åçã®èæ¯ãè¸ã¾ããæ¹å®ãããã¨ã¨ãã¾ãããä»è¬ããå»çæ å ±ãåãæ±ãæ å ±ã·ã¹ãã ã»ãµã¼ãã¹ã®æä¾äºæ¥è ã«ãããå®å ¨ç®¡çã¬ã¤ãã©ã¤ã³ç¬¬2.0çï¼æ¡ï¼ããåãã¾ã¨ãã¾ããã®ã§ã令å6å¹´10æ2æ¥ï¼æ°´ï¼ããåå¹´10æ31æ¥ï¼æ¨ï¼ã¾ã§ã®éï¼30æ¥éï¼ãåã¬ã¤ãã©ã¤ã³æ¡ã«å¯¾ããæè¦ãåéãã¾ãã ç·åçåã³çµæ¸ç£æ¥çã§ã¯ãå»çæ å ±ã®å®å ¨ç®¡çã®ãããå»çæ å ±ãåãæ±ãæ å ±ã·ã¹ãã ããµã¼ãã¹ã®æä¾äºæ¥è ãéµå®ãã¹ãå 容ãã¾ã¨ããã¬ã¤ãã©ã¤ã³ã¨ãã¦ã令
5æ31æ¥ãæ¥æ¯è°·å ¬åã«ã¦ãWHOããå½ãå®ãå½æ°éå 大決起éä¼ããªã大ä¼ãéããã¾ãããå¹³æ¥ã«ããããããéå¤é³æ¥½å ã¯è¶ æºå¡ã¨ãªãã溢ãã人ã ã®åãééããæ¾æ¬æ¥¼ã¾ã§ã®éã®ããåãå°½ããã¾ããã (人ã§æº¢ããæ¥æ¯è°·å ¬å) 大ä¼ã®å¾è¡ãããé座ãã京æ©ã¾ã§ã®ãã¢è¡é²ã¯3æéãè¶ ãã¦ãéåãéåãããã¨ç¡ããè¦å¯å´ã®è¦è«ã«ããä¸æããäºæ ã¨ãªãã¾ãããåå è ç·æ°ã¯ä¸»å¬å´ã®ã¤ã³ã¿ãã¥ã¼ã«ããã°ä¸ä¸äºå人ãç¾å°ã«èµ´ãã(çè å«ã)ã¦ã©ããã£ã¼ã®éè¨ãä¸ä¸äººåå¾ã¨ãªã£ã¦ãã¾ãã ãã®éä¼ã«ã¯æ ¶æ義塾大å¦åèªææã®æ²æ³å¦è ã§ããå°æç¯ãåå ããä»æ¥ããç§ããã®éåã«åå ãã¾ãï¼é°è¬è«è ã¨è¨ããã¦ãããã§ãï¼ãã¨è¨ãæ¾ã£ããã¨ã§è©±é¡ã¨ãªãã¾ããããå ±åéä¿¡ã®åæã«ããã¨ãå°æã¯éä¼ã«åå ãããã¨ã«ã¤ãã¦å¾æãã¦ããããã§ãã å°ææ°ã¯éä¼ã«åå ãããã¨ãã©ãèãã¦ããã®ã ããããåæã«å¯¾ããå°ææ°ã¯
鹿å 島çå»å¸«ä¼ã«ããâä¸èªç¶ãªçµç·¯âã¾ãã¯ã鹿å 島çè¦ã«ããä¸é£ã®åé¡ãæ¯ãè¿ã£ã¦ãããã ã鹿å 島çè¦ã«å ¨å½ã®ç®ãåããã®ã¯ãä»å¹´3æã«éè·ããçè¦å è¦è¦æ£ã§åçæ´»å®å ¨é¨é·ã®æ¬ç°å°å¿è¢«åï¼60ï¼ï¼å½å®¶å ¬åå¡æ³éå罪ã§èµ·è¨´ï¼ããå é¨è³æãããªã¼ã¸ã£ã¼ããªã¹ãã«æ¼ããããã¨ãã¦5æ30æ¥ã«é®æããããã¨ããã£ããã§ãã æ¬ç°è¢«åã¯ãã®åæ©ã«ã¤ãã¦ãçæ®å®¹çãããç¾è·è¦å¯å®ã¸ã®ææ»ãçè¦ãããã®éå·æè¼æ¬é¨é·ãæ¢ããã¨ãããçè¦è¦å¯å®ã®ç¯ç½ªè¡çºããéå·æè¼æ¬é¨é·ãé è½ãããã¨ãããã¡è¦å¯å®ã¨ãã¦ã©ããã¦ã許ããªãã£ããã¨ä¸»å¼µãã¾ããããããæ¬å½ãªããæ¬ç°è¢«åã®è¡çºã¯ç§å¯æ¼ããã§ã¯ãªããå ¬çéå ±ã«ãããå¯è½æ§ãããã¾ãã ããããçè¦ãå¥äºä»¶ã®ææ»åç®ã§ç¦å²¡ã®ãã¥ã¼ã¹ãµã¤ãããã³ã¿ã¼ãã«è¡ãªã£ãå®¶å® æç´¢ã§æ¼åããè³æãããæ¬ç°è¢«åã®â容çâãæµ®ä¸ãããã¨ããããã¾ããããã®å¾ãå¤ãã®ã¡ãã£ã¢ãå
令åï¼å¹´ï¼æï¼æ¥ å»çæ³äººç¤¾å£ç¥çä¼ã«å¯¾ããæ¯å表示æ³ã«åºã¥ãæªç½®å½ä»¤ã«ã¤ã㦠æ¶è²»è åºã¯ã令åï¼å¹´ï¼æï¼æ¥ãå»çæ³äººç¤¾å£ç¥çä¼ï¼ä»¥ä¸ãç¥çä¼ãã¨ã ãã¾ãã ï¼ ã«å¯¾ãã åæ³äººãéå¶ãã ããããã大森å ç§ã¯ãªããã¯ã ï¼ä»¥ä¸ ã㯠ãªããã¯ãã¨ããã¾ãã ï¼ã¨ç§°ãã診çæã«ããã¦ä¾çµ¦ãã診çãµã¼ãã¹ã«ä¿ ã表示ã«ã¤ãã¦ãæ¯å表示æ³ã«éåããè¡çºï¼åæ³ç¬¬ï¼æ¡ç¬¬ï¼å·ï¼ã¹ãã«ã¹ã ã¼ã±ãã£ã³ã°å示ï¼ã«è©²å½ï¼ãèªãããããã¨ãããåæ³ç¬¬ï¼æ¡ç¬¬ï¼é ã®è¦å® ã«åºã¥ããæªç½®å½ä»¤ï¼å¥æ·»åç §ï¼ãè¡ãã¾ããã ï¼ éåè¡çºè ã®æ¦è¦ å 称 å»çæ³äººç¤¾å£ç¥çä¼ï¼æ³äººçªå· 9010805002735ï¼ æ å¨ å° æ±äº¬é½å¤§ç°åºå¤§æ£®è¥¿ä¸ä¸ç®ï¼çªï¼ï¼å·ãããã大森ï¼é 代 表 è çäºé· æ²³å å è¨ç«å¹´æ 令åï¼å¹´ï¼æ è³ç£ã®ç·é¡ ï¼åï¼ï¼ï¼ï¼ä¸ï¼ï¼ï¼ï¼åï¼ä»¤åï¼å¹´ï¼æç¾å¨ï¼ ï¼ æªç½®å½ä»¤ã®æ¦è¦ ⴠ対象役å
X(æ§Twitter)ãã¯ããã¨ããã½ã¼ã·ã£ã«ãããã¯ã¼ã¯ã§ã¯ãä¸é¨ã®å»å¸«ããªã¹ã¹ã¡ã®å»è¬åãªã©ãç´¹ä»ããæ稿ãæ£è¦ããã¾ããã¢ã¡ãªã«ã®ããã¤ãã®æ©é¢ã«æå±ããå»å¦ç 究è ã®ãã¼ã ããXã§å»è¬åãç´¹ä»ããå»å¸«ã®å¤ããå»è¬åã¡ã¼ã«ã¼ããå ±é ¬ãåãåã£ã¦ãããã¨ãææãã¦ãã¾ãã Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform | Ethics | JAMA | JAMA Network https://jamanetwork.com/journals/jama/article-abstract/2819356 Study shows most doctors endorsing drugs on X are paid to do so https://medicalxp
令å6å¹´5æ19æ¥åå¾4æé ãããå½ã»ã³ã¿ã¼åã³æ±å¤æ¾ãµã³ã¯ã診çæã®é»åã«ã«ããå«ããç·åæ å ±ã·ã¹ãã ã«æ¯éãçãã¦ãã¾ããå°åã«ãããç²¾ç¥ç§å»çã®ä¸æ ¸çãªå½¹å²ãæ ãç é¢ã¨ãã¦ãçæ°ã®çæ§ãç¹ã«æ£è ãããã¯ããã¨ããé¢ä¿è ã®çæ§ã«å¤å¤§ãªããè¿·æããå¿é ãããããã¾ããã¨ã«æ·±ããè©«ã³ç³ãä¸ãã¾ãã ãµã¤ãã¼æ»æã®å¯è½æ§ããããã¨ãããç´ã¡ã«ã岡山çã岡山çè¦ãåçå´åçãªã©ã®åæ¹é¢ã«é£çµ¡ãããã¨ã¨ãã«ãåå ã®ç©¶æãæ©æã®å¾©æ§ã«åªãã¦ããã¾ãã å½é¢ãç´ã«ã«ãã®éç¨ãªã©ã«ãã診çä½å¶ã®ç¶æã«åãçµãã§ã¾ããã¾ãã ãªããç¾å¨ã®ã¨ãããå人æ å ±çã®æ¼æ´©ã®äºå®ã¯ç¢ºèªããã¦ããã¾ããã ãç解ããååã®ã»ã©ãã©ãããããããé¡ãç³ãä¸ãã¾ãã 令å6å¹´5æ20æ¥ é¢é· æ¥ä½ ç±æ¨¹
ãå»çæ å ±ã·ã¹ãã ã®å®å ¨ç®¡çã«é¢ããã¬ã¤ãã©ã¤ã³ãï¼ä»¥ä¸ãã¬ã¤ãã©ã¤ã³ãã¨ãããï¼ã«ã¤ãã¦ã¯ãç´è¿ã§ã¯ä»¤åï¼å¹´ï¼æã«ç¬¬5.2 çãçå®ããå»çæ å ±ã·ã¹ãã ã®é©åãªåæ±ãçã«ã¤ãã¦ã示ããã¦ããã¨ããã§ããä»è¬ãã¬ã¤ãã©ã¤ã³ã®è¦ç´ããè¡ãã以ä¸ã®ã¨ãããå»çæ å ±ã·ã¹ãã ã®å®å ¨ç®¡çã«é¢ããã¬ã¤ãã©ã¤ã³ç¬¬6.0 çããçå®ããã¨ã¨ãã«ãå¥æ·»ãç¹éãQ&Açã®åèè³æãä½æãã¾ããããªããæ¹å®ã®è¶£æ¨ãæ¦è¦ã«ã¤ãã¦ã¯ä»¥ä¸ã®ã¨ããã§ãã ç¬¬ï¼ æ¹å®ã®è¶£æ¨ ä¿éºå»çæ©é¢ã»è¬å±ã«ããã¦ã¯ä»¤åï¼å¹´ï¼æãããªã³ã©ã¤ã³è³æ ¼ç¢ºèªã®å°å ¥ãåå義ååããã¦ãããä»å¾ã¯ã¬ã¤ãã©ã¤ã³ã«è¨è¼ããã¦ãããããã¯ã¼ã¯é¢é£ã®ã»ãã¥ãªãã£å¯¾çãããå¤ãã®å»çæ©é¢çã«å ±éãã¦æ±ãããããã¨ã¨ãªãããã£ã¦ãå»çæ©é¢çã«ã¬ã¤ãã©ã¤ã³ã®å 容ã®ç解ãä¿ããå»çæ å ±ã·ã¹ãã ã®å®å ¨ç®¡çã®å®å¹æ§ãé«ãããããæ§æã®è¦ç´ããè¡ããã¾ããå»ççåéå
å¶æ´¥å²³å£«ã大éªæ¥æ§æã»ç·åå»çã»ã³ã¿ã¼ãç·é· 岩ç¬åè£ã大éªæ¥æ§æã»ç·åå»çã»ã³ã¿ã¼ãç é¢é· é è¤æ³°å²ãã¤ããçºç«åç°ç é¢ãç é¢äºæ¥ç®¡çè ä¸åé 彦ãã¤ããçºç«åç°ç é¢ãç é¢é· ãã¤ã¦ãªãè¦æ¨¡ã®ãµã¤ãã¼æ»æãåããæ å ±ã»ãã¥ãªãã£ã¤ã³ã·ãã³ããçºçããã¤ããçºç«åç°ç é¢ã¨å¤§éªæ¥æ§æã»ç·åå»çã»ã³ã¿ã¼ã第1åã§ã¯çºçåã®ã»ãã¥ãªãã£ä½å¶ã«ã¤ãã¦æ¯ãè¿ãã¾ãããã第2åã§ã¯ãããããã®ç é¢ã§ã¤ã³ã·ãã³ããçºçããæã®ç¶æ³ã«ã¤ãã¦è©±ã伺ãã¾ããã èãæï¼è©åå¥å¤ªï¼ä¸è¬ç¤¾å£æ³äºº ã½ããã¦ã§ã¢åä¼ï¼ çºçãã1ã¶æ以ä¸ãé常æ¥åã«æ¯éãçãã被害ââ大éªæ¥æ§æã»ç·åå»çã»ã³ã¿ã¼ã§ã¤ã³ã·ãã³ãçºçã®ä¸å ±ãèããæã®ç¶æ³ãå¿å¢ã«ã¤ãã¦ãèãããã ãããå¶æ´¥ï¼å¤§éªæ¥æ§æã»ç·åå»çã»ã³ã¿ã¼ï¼ï¼æåã«ãé¢å ã®ã³ã³ãã¥ã¼ã¿ãã¦ã¤ã«ã¹ã«ææãã¦ããæ å ±ã·ã¹ãã ãã¡ããã¨åãã¾ãããã¨èãã¾ããããã¼ã¿ãèªããªã
æ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã®å¾éºçã«ã¯ãããã¬ã¤ã³ãã©ã°ãã¨å¼ã°ããé ã®ä¸ã«é§ããããããã£ãããã«ãªããæèãéä¸åãéããªãçç¶ãåå¨ãã¾ãããã®ãã¬ã¤ã³ãã©ã°ã®åå ããè³è¡ç®¡ããã®åºè¡ã§ãããã¨ãå¤æãã¾ããã Bloodâbrain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment | Nature Neuroscience https://www.nature.com/articles/s41593-024-01576-9 Leaky Blood Vessels: Underlying Cause of Long COVID âBrain Fogâ Discovered http
éè¿ã«è¿«ãå½å å»çã»ãã¥ãªãã£è¦å¶å¯¾å¿ã®æéããããã©ã¤ã³ã¯2024å¹´3ææ«ã«ãï¼å»çãµã¤ãã¼ã»ãã¥ãªãã£ææ°ååï¼3ï¼ï¼1/3 ãã¼ã¸ï¼ å»çåéã«ããããµã¤ãã¼ã»ãã¥ãªãã£ã®ææ°ååãç´¹ä»ããã¨ã¨ãã«ãä»å¾ã®å»çæ©å¨éçºã®é²ãæ¹ãªã©ã«ã¤ãã¦èª¬æããæ¬é£è¼ã第3åã¯ã2024å¹´3ææ«ã«ãæéãè¿ããå½å å»çé¢é£ãµã¤ãã¼ã»ãã¥ãªãã£ã®è¦å¶ã«å¯¾ãã¦ãå»çæ å ±ã·ã¹ãã ãå»çæ©å¨ã®ã¡ã¼ã«ã¼ãä»ããã«åãã¹ã対å¿ã«ã¤ãã¦è§£èª¬ããã æ¬é£è¼ã§ã¯ãå»çåéã«ããããµã¤ãã¼ã»ãã¥ãªãã£ã®ææ°ååãç´¹ä»ããã¨ã¨ãã«ãä»å¾ã®å»çæ©å¨éçºã®é²ãæ¹ãªã©ã«ã¤ãã¦èª¬æãã¾ãã 第1åã¯å»çåéã§æ¥å¢ãããµã¤ãã¼æ»æã®ç¶æ³ã¨æ¥æ¬æ¿åºã®å¯¾å¿ãåãä¸ãã第2åã¯å½å ã«ãããå»çé¢é£åéãä¸å¿ã¨ãããµã¤ãã¼ã»ãã¥ãªãã£ã®è¦å¶ååã«ã¤ãã¦ç´¹ä»ãã¾ãããæçµåã¨ãªãä»åã®ç¬¬3åã§ã¯ããµã¤ãã¼ã»ãã¥ãªãã£ã®è¦å¶ãåãã¦å»çæ å ±ã·
令åï¼å¹´ï¼æï¼ï¼æ¥ X ç·ç»åèªå½±ã·ã¹ãã ã¸ã®ä¸æ£ã¢ã¯ã»ã¹ã«ã¤ã㦠令åï¼å¹´ 1 æï¼ï¼æ¥ï¼æï¼ ãå½äºæ¥å£ãä¿æãã X ç·ç»åèªå½±ã·ã¹ãã ãã©ã³ãµã ã¦ã§ã¢ ã«ããä¸æ£ã¢ã¯ã»ã¹æ»æï¼èº«ä»£éè¦æ±åãµã¤ãã¼æ»æï¼ãåãããã¨ã確èªãã¾ããã ç¾å¨ã被害ã®æ¡å¤§ãé²æ¢ããããã«ãããã¯ã¼ã¯ãé®æããä¸æ£ã¢ã¯ã»ã¹ãåããç¯å² ã®ç¹å®ãä¸æ£ã¢ã¯ã»ã¹ã®åå 調æ»ã復æ§ä½æ¥ãé²ãã¦ããã¾ããç¾æç¹ã«ããã¦æ¼æ´©ãã å¯è½æ§ã®ããå人æ å ±åã³ X ç·ç»åèªå½±ã·ã¹ãã ã®å¾©æ§ã®è¦éãã«ã¤ãã¦ã¯ãä¸è¨ã®ã¨ã ãã§ãããã詳ããç¶æ³ãå¤æ次第ãéããã«ãç¥ãããããã¾ãã é¢ä¿è ã®çæ§ã«ã¯ãå¤å¤§ãªããè¿·æåã³ãå¿é ãããããã¾ããã¨ããæ·±ããè©«ã³ç³ã ä¸ãã¾ãã è¨ ï¼ æ¼æ´©ããå¯è½æ§ã®ããå人æ å ± ç¾å¨ã·ã¹ãã æ¥è ã«ããã¦èª¿æ»ãé²ãã¦ããã¾ãããç¾æç¹ã§æ¼æ´©ããå¯è½æ§ã®ã ãå人æ å ±ã¯ãX ç·ç»åï¼è¸é¨ãèé¨ãä¹³é¨
å¼çã»å·è¶ã«ãããå¼çå»ç§å¤§å¦ç·åå»çã»ã³ã¿ã¼é«åº¦æå½ææ¥ã»ã³ã¿ã¼ãã®å ¬å¼Xï¼ãã¤ãã¿ã¼ï¼ã2023å¹´11æ30æ¥ãæ°æ¥åã«æ£è æ å ±ã¨ã¨ãã«ãCTç»åããæ稿ããã¨ããåé¡è¦ããããã¨ãåããã¢ã«ã¦ã³ãããç¡æéã§ã®ä¼æ¢ãã«ããã¨çºè¡¨ããã åé¡ã®æ稿ã¯æ¢ã«åé¤ããã¦ãããå人ãæ¨å¯ã§ããªãããé æ ®ãã¦ããã¨ãããå°ãã§ãæå½ã®ç¾å ´ãç®æãæ¹ã ã«èå³ãæã£ã¦ããããã¨ãã¦ã®ãã¨ã§ããããå½ã»ã³ã¿ã¼ã®ä¿¡é ¼ãèããæãªãä¸é©åãªæ稿ã§ããã¾ãããã¨ãä¼ããã ãä»å¾ãä¿¡é ¼å復ã«åªãã¦ã¾ããã¾ãã åã¢ã«ã¦ã³ãã¯27æ¥ãããããã¿ããä½ã«çæãã¦ä½ããã¾ããï¼ãã¨åãã¤ã¤ãæ£è æ å ±ã¨ä½µãã¦CTç»åãæ稿ãããæ稿ã¯ã«ããã«æ¡æ£ãããããããSNSã§ãããã¨ãï¼ããæ£è ããã®åæã¯åãã¦ã¾ãããã¨ãã£ãææãä¸ããäºæ ã¨ãªã£ãã åé¿ãåãã¦28æ¥ã«ã¯ããå½ã¢ã«ã¦ã³ãã§å ¬éãã診çæ å ±ã¯ãå æ¬çå
ã¹ã¦ã§ã¼ãã³ã®ãã¼ãã«è³å§å¡ä¼ã2023å¹´10æ2æ¥ã«ãæ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã®ã¯ã¯ãã³ã§ããmRNAã¯ã¯ãã³éçºã«å¤å¤§ãªè²¢ç®ãããçåå¦è ã®ã«ã¿ãªã³ã»ã«ãªã³æ°ã¨å ç«å¦è ã®ããªã¥ã¼ã»ã¯ã¤ãºãã³æ°ã«ã2023å¹´ã®ãã¼ãã«ççå¦ã»å»å¦è³ãæä¸ãããã¨ãçºè¡¨ãã¾ããã Press release: The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org https://www.nobelprize.org/prizes/medicine/2023/press-release/ Nobel Prize in medicine awarded for work on mRNA Covid vaccines by Katalin Kariko and Drew Weissman | CNN https://e
1 2023 å¹´ 9 æ 19 æ¥ æ ªå¼ä¼ç¤¾ HIROTSU ãã¤ãªãµã¤ã¨ã³ã¹ ä¸é¨ã¡ãã£ã¢ã§ã®å ±éã«ã¤ã㦠å è¬ä¸é¨ã¡ãã£ã¢ãå ±ãããN-NOSE 並ã³ã«å¼ç¤¾ã¬ããã³ã¹ãã¾ã代表åç· å½¹ã糾弾ããè¨äºã«ã¤ã㦠å¼ç¤¾å ã«ã¦ç²¾æ»ããçµæãäºå®ã¨ç°ãªãè¨è¼ãå¤æ°ç¢ºèªãã¾ããããã®å¤ãã¯ãè¨è ã®æãè¾¼ã¿ãç¥èä¸ è¶³ã«ããæ¸ãããã¨æ¨å¯ãã¾ãããä¸ã«ã¯çéããããé大ãã¤æªè³ªãªã誤æ å ±ããå«ã¾ãã¦ããã¾ãã ã®ã§ãããã«å½è©²ç®æãææããã¨å ±ã«è¨æ£ãããã¾ãã æ¬æ¥ãç§å¦ã®è°è«ã¯ãã®ã«ã¼ã«ã«åã£ã¦è¡ãã¹ããã®ã§ãããä»åã®è¨äºã¯å¤§ããé¸è±ãã¦ãã¾ããå¾ è¿°ãããè¨ç®ãã¹ãã«ãã£ã¦å°ãåºãããæ度 13ï¼ ãã¨ããæ°åãããããåããããã証æ ã®ããã«æ² ããããã«ãå¼ç¤¾ã«æ¹å¤çãªé¢ä¿è ã®ä¸æ¹çãªè¨¼è¨ãè³æçã§å¡ãåºããã¨ãã£ãå°è±¡æä½ã«ãã£ã¦ãã ããããªãæé ãä¸æ£ãã§ã£ã¡ãããè¨äºå 容ã¨ãã®åææ
ã¢ã¡ãªã«ç¾ç äºé²ç®¡çã»ã³ã¿ã¼(CDC)ã¯2023å¹´9æ12æ¥ã«ãçå¾6ã«æ以ä¸ã®ãã¹ã¦ã®äººã«æ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã«å¯¾ããã¯ã¯ãã³ã追å æ¥ç¨®ããããã«æ¨å¥¨ãã¦ãã¾ããããã¾ã§ã®ã¯ã¯ãã³ã¨ãä»åCDCãæ¥ç¨®ãæ¨å¥¨ããã¯ã¯ãã³ãã©ãéããã«ã¤ãã¦ããµã¦ã¹ã«ãã©ã¤ã大å¦ã®ãã©ã«ã·ã¥ã»ãã¬ã«ã«ããã£æ°ãã解説ãã¦ãã¾ãã CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered https://theconversation.com/cdc-greenlights-two-updated-covid-19-vaccines-but-how-will-they-fare-against-the-la
ããª2024 è½ç»å島å°é éå ± æå è¨äºä¸è¦§ ç´é¢ãã¥ã¼ã¢ã¼ å¤å è¨äºä¸è¦§ ç´é¢ãã¥ã¼ã¢ã¼ é£è¼ ã©ã³ãã³ã° ãã®ä» ã³ã¡ã³ããã©ã¹ ãã¥ã¼ã¹ã®è¦ç¹ ç¹é åç»ã»é³å£°ã»åç åæå¥å·ããbeã è¨è ã¤ãã³ã å¤©æ° æ°ç¬ 12æ座å ã ãµã¤ãããã æ¤ç´¢ ãã«ã Q&Aï¼ãããã質åï¼ ç·åã¬ã¤ã ãç³ã込㿠ãã°ã¤ã³ ãã¤ãã¼ã¸ ææä¼å¡ç´é¢ãã¥ã¼ã¢ã¼ã³ã¼ã¹ç»é²æ¸ã¿ ç¡æä¼å¡ï¼ã¯ã¼ãã³é©ç¨ä¸ï¼ç´é¢ãã¥ã¼ã¢ã¼ã³ã¼ã¹ç»é²æ¸ã¿ ç¡æä¼å¡ç´é¢ãã¥ã¼ã¢ã¼ã³ã¼ã¹ç»é²æ¸ã¿ ææ¥IDä¼å¡ ç´é¢ãã¥ã¼ã¢ã¼ã³ã¼ã¹ ã客æ§ãµãã¼ãï¼å人è¨å®ï¼ ã客æ§ãµãã¼ãï¼å人è¨å®ï¼ ã客æ§ãµãã¼ãï¼å人è¨å®ï¼ ã¡ã¼ã«è¨å® ã¹ã¯ã©ãããã㯠MYãã¼ã¯ã¼ã ä¼å¡ç¹å ¸ã»ãã¬ã¼ã³ã ææºãã¬ãã¢ã ãµã¼ãã¹ ãã°ã¢ã¦ã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}